The Taiwan Monthly
Nov. 2026
Listed Companies and Initial Public Offerings
Elixiron Immunotherapeutics (Cayman) Limited has submitted its application for listing on tib on September 22, 2026
Elixiron Immunotherapeutics (Cayman) Limited (Code: 7871) has submitted its application for listing on the Taiwan Innovation Board (tib) on September 22, 2026. A total of 6 companies have submitted tib listing applications this year as of September 22.